Scholars Central

Conference abstractPublished 27 Dec 2017

Association of 4874 A/G (rs4969170) polymorphism in SOCS3 gene promoter region and RNA expression with liver fibrosis progression in patients with chronic hepatitis C

Authors: Jadid Fatima Zahra, Chihab Hajar, Elfihry Raouia, Zaidane Imane, Salih Alj Hanane, Saile Rachid, Alaoui Rhimou, Badre Wafaa, Tazi Sanaa, Pascal Pineau, Ezzikouri Sayeh, Benjelloun Soumaya

Institut Pasteur du Maroc, Morocco UniversitÃ?© Hassan II, Morocco Institut Pasteur, France Service de Medecine B, Morocco

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Context: Chronic hepatitis C virus infection (CHC) is one of the most important risk factor of hepatocellular carcinoma (HCC). However, the pathogenesis of Insulin Resistance (IR) in hepatitis C infection is a very intriguing problem. In fact, the HCV is now recognized responsible for direct interference with the insulin signaling pathway. In addition, HCV-related IR has been shown to have a remarkable clinical impact on the progression of hepatic fibrosis and development of HCC. Objective: The present study aims to evaluate the association of 4874 A/G (rs4969170) polymorphism in SOCS3 gene promoter region and RNA expression with liver fibrosis progression in chronic hepatitis C infected patients. Materiel & Methods: In this study 226 Moroccan patients chronically infected with HCV (95 patients with mild fibrosis and 131 patients with advanced fibrosis) were genotyped for 4874 A/G (rs4969170) variant using the real time PCR. SOCS3 mRNA expression analysis was performed by using Sybr Green. Logistic regression was used to assess the association between polymorphism and progression of HCV infection. Results: A significant difference in genotypes distribution of rs4969170 was detected between mild and advanced fibrosis group. The AA genotype was significantly overrepresented in Ad-LD patients compared to m-LD, the AA genotype was associated with a 5-fold increase of AdLD risk when compared to mild chronic hepatitis C (OR = 5.14; 95% CI, 2.29 - 11.54; P=0.00004). A similar situation was observed with the dominance model (OR = 4.18; 95% CI, 2.19 - 7.97; P=6.374e-06). The relative expression of SOCS3 to GAPDH mRNA was increased by 2 fold in Ad-LD as compared to m-LD group with AA genotype. Conclusion: Our results suggest that polymorphism in SOCS3 gene promoter modulates the progression of chronic hepatitis C infection toward advanced liver disease by affecting its mRNA expression.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Gastrointestinal & Digestive System.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Gastrointestinal & Digestive System
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Jadid Fatima Zahra”
  • BylineArticles whose byline prints “Chihab Hajar”
  • BylineArticles whose byline prints “Elfihry Raouia”
  • BylineArticles whose byline prints “Zaidane Imane”
  • BylineArticles whose byline prints “Salih Alj Hanane”
  • BylineArticles whose byline prints “Saile Rachid”
  • BylineArticles whose byline prints “Alaoui Rhimou”
  • BylineArticles whose byline prints “Badre Wafaa”